EP 1061908 A4 20070124 - COMBINATION THERAPY AND COMPOSITION FOR ACUTE CORONARY ISCHEMIC SYNDROME AND RELATED CONDITIONS
Title (en)
COMBINATION THERAPY AND COMPOSITION FOR ACUTE CORONARY ISCHEMIC SYNDROME AND RELATED CONDITIONS
Title (de)
KOMBINATIONSTHERAPIE UND ZUSAMMENSTELLUNG FÜR AKUTES KORONARISCHÄMIESYNDROM UND DAMIT ZUSAMMENHÄNGENDE ZUSTÄNDE
Title (fr)
THERAPIE ASSOCIEE DESTINEE AU SYNDROME ISCHEMIQUE CORONARIEN AIGU AINSI QU'A DES TROUBLES CONNEXES
Publication
Application
Priority
- GB 9815857 A 19980721
- US 9905063 W 19990309
- US 7790098 P 19980313
Abstract (en)
[origin: WO9945913A1] The invention provides a method for treating, preventing, or reducing the risk of developing a condition selected from the group consisting of acute coronary ischemic syndrome, thrombosis, thromboembolism, thrombotic occlusion and reocclusion, restenosis, transient ischemic attack, and first or subsequent thrombotic stroke, in a patient, comprising administering to the patient a therapeutically effective amount of an antiplatelet agent in combination with a therapeutically effective amount of a COX-2 inhibitor. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a COX-2 inhibitor, or a pharmaceutically acceptable salt thereof, and an antiplatelet agent, or a pharmaceutically acceptable salt thereof.
IPC 1-7
IPC 8 full level
A61K 31/122 (2006.01); A61K 31/194 (2006.01); A61K 31/225 (2006.01); A61K 31/341 (2006.01); A61K 31/40 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/4418 (2006.01); A61K 31/4427 (2006.01); A61K 31/444 (2006.01); A61K 31/445 (2006.01); A61K 31/4465 (2006.01); A61K 31/45 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 31/5517 (2006.01); A61K 38/05 (2006.01); A61K 38/08 (2019.01); A61K 45/06 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 43/00 (2006.01); C07D 211/46 (2006.01); C07D 211/76 (2006.01); C07D 213/61 (2006.01); C07D 307/32 (2006.01); C07D 307/33 (2006.01); C07D 401/12 (2006.01); C07D 487/04 (2006.01)
CPC (source: EP US)
A61K 38/05 (2013.01 - EP); A61K 38/08 (2013.01 - EP US); A61K 45/06 (2013.01 - EP); A61P 7/02 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
- [A] WO 9800416 A1 19980108 - MERCK & CO INC [US], et al
- [A] WO 9745420 A1 19971204 - MERCK & CO INC [US], et al
- [A] WO 9744028 A1 19971127 - MERCK & CO INC [US], et al
- [A] WO 9744027 A1 19971127 - MERCK & CO INC [US], et al
- [A] WO 9738986 A1 19971023 - SEARLE & CO [US], et al
- [A] WO 9729753 A1 19970821 - SANOFI SA [FR], et al
- [A] WO 9721445 A1 19970619 - OMEROS MED SYS INC [US], et al
- [A] GB 2105988 A 19830407 - ROCADOR SA [ES]
- See references of WO 9945913A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 9945913 A1 19990916; CA 2322824 A1 19990916; EP 1061908 A1 20001227; EP 1061908 A4 20070124; JP 2002506024 A 20020226
DOCDB simple family (application)
US 9905063 W 19990309; CA 2322824 A 19990309; EP 99911208 A 19990309; JP 2000535328 A 19990309